Decibel Maximizes Every Data Point
Decibel Maximizes Every Data Point with eClinical and elluminate
With the elluminate® Clinical Data Platform, Decibel Therapeutics proactively manages and monitors data across a growing portfolio. Centralized, standardized data inform analytics for democratized data access across stakeholders, and Decibel gains maximum data control and quality in an outsourced model.
As a biotechnology company specializing in clinical trials for rare diseases, Decibel Therapeutics needed to make the most of their many data sources. Like many emerging biotech companies experiencing rapid growth, they were contending with resource constraints and aggressive timelines. Decibel knew that they needed a centralized platform capable of integrating multiple new data sources as trials evolved. They wanted a platform that could standardize data sources for efficient data review and scalability that could be rapidly implemented by a small team.
Decibel found that eClinical Solutions’ elluminate was an excellent fit for their current requirements and for the future. Despite having diverse data sources — including animal studies and natural progression studies — the elluminate Mapper product was able to aggregate and standardize all ingested data. Centralized data and alerts for missing or incorrect data allow for a more efficient data review process. With elluminate, data can be annotated and analytics and visualization can be layered, increasing the ability to share insights.
Decibel quickly saw value in the time saved in analysis by providing quick access to data by end users. The company plans to continue to build out more data visualizations to allow for greater access to their clinical data. They are also working with their audiologist on medical monitoring, with the information gleaned going directly into the elluminate platform. As they scale up their trials, Decibel plans to use elluminate for more processes. They also anticipate that they will be able to further minimize the time between Last Patient Last Visit (LPLV) and database lock.
Like many emerging biotech companies experiencing rapid growth, Decibel was contending with resource constraints and aggressive timelines. By investing in elluminate, they were able to scale development operations and increase visibility to stakeholders with Data Central, Analytics, and Mapper.
Powerful data transformation, unification and automation from diverse data sources and formats without programming for submission and analytic needs.
All your trial data from every source, one place for integrated review- listings, patient profiles, analytics, queries and issue management.
Comprehensive visualizations and reporting that support safety and efficacy decisions within and across trials, operational analytics that help proactively manage your trial.
elluminate Implementation services allowed Decibel Therapeutics greater data control and quality while working in a highly outsourced model. With eClinical, Decibel has maximum data ownership and the flexibility to adapt to trial and portfolio changes.
Even using elluminate just for the SDTM mapping, we instantly saw value in the product.
Chief Data Science Officer
Ready to take charge of your clinical data strategy?
Schedule a demo and/or speak to an eClinical Solutions representative to learn more.